We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
-11.93%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.06B
AUM Growth
+$226M
Cap. Flow
+$653M
Cap. Flow %
21.38%
Top 10 Hldgs %
83.2%
Holding
374
New
73
Increased
133
Reduced
109
Closed
49

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$334M
2
JD icon
JD.com
JD
+$84.6M
3
BIDU icon
Baidu
BIDU
+$84.3M
4
NTES icon
NetEase
NTES
+$50.9M
5
PDD icon
Pinduoduo
PDD
+$50.6M

Top Sells

Rank Stock Value
1
NIO icon
NIO
NIO
+$10.7M
2
KC
Kingsoft Cloud Holdings
KC
+$9.2M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$7.55M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$7.48M
5
MOMO
Hello Group
MOMO
+$6.64M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 63.45%
2 Communication Services 21.89%
3 Technology 6.77%
4 Healthcare 2.16%
5 Financials 1.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICPT
301
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$186K 0.01%
+11,431
New +$179K
MYOV
302
DELISTED
Myovant Sciences Ltd.
MYOV
$181K 0.01%
+13,601
New +$182K
ATRA icon
303
Atara Biotherapeutics
ATRA
$89.3M
$180K 0.01%
+777
New +$247K
CHRS icon
304
Coherus Oncology
CHRS
$221M
$174K 0.01%
+13,486
New +$171K
KYNB
305
Kyntra Bio
KYNB
$32.2M
$167K 0.01%
+556
New +$194K
DMTK
306
DELISTED
DermTech, Inc. Common Stock
DMTK
$164K 0.01%
+11,153
New +$149K
ALEC icon
307
Alector
ALEC
$265M
$163K 0.01%
+11,434
New +$181K
MNKD icon
308
MannKind Corp
MNKD
$1.27B
$160K 0.01%
43,489
+17,038
+64% +$62.3K
AGEN
309
Agenus
AGEN
$349M
$144K ﹤0.01%
2,984
+254
+9% +$13.7K
VTRS icon
310
Viatris
VTRS
$18.9B
$142K ﹤0.01%
13,088
+734
+6% +$9.67K
SGMO
311
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$134K ﹤0.01%
23,101
+11,383
+97% +$67.7K
IBRX icon
312
ImmunityBio
IBRX
$8.43B
$128K ﹤0.01%
22,816
+7,933
+53% +$48.7K
RDUS
313
DELISTED
Radius Health, Inc.
RDUS
$112K ﹤0.01%
12,738
+1,981
+18% +$15K
MCRB icon
314
Seres Therapeutics
MCRB
$50M
$106K ﹤0.01%
744
+207
+39% +$31.8K
GTHX
315
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$98K ﹤0.01%
12,869
+1,542
+14% +$14.6K
CPRX
316
DELISTED
Catalyst Pharmaceutical
CPRX
$96K ﹤0.01%
+11,614
New +$82.1K
MGNX icon
317
MacroGenics
MGNX
$255M
$92K ﹤0.01%
+10,417
New +$115K
ORGO icon
318
Organogenesis Holdings
ORGO
$220M
$90K ﹤0.01%
11,780
-769
-6% -$5.95K
VBIV
319
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$88K ﹤0.01%
1,772
+878
+98% +$43.4K
ADAG
320
Adagene
ADAG
$251M
$69K ﹤0.01%
19,310
-34,775
-64% -$219K
CMRX
321
DELISTED
Chimerix, Inc.
CMRX
$59K ﹤0.01%
+12,868
New +$71.7K
RIGL icon
322
Rigel Pharmaceuticals
RIGL
$857M
$52K ﹤0.01%
1,747
+140
+9% +$3.79K
MDXG icon
323
MiMedx Group
MDXG
$662M
$50K ﹤0.01%
+10,673
New +$52.2K
GERN icon
324
Geron
GERN
$964M
$43K ﹤0.01%
31,687
+12,869
+68% +$14.3K
AKBA icon
325
Akebia Therapeutics
AKBA
$244M
$25K ﹤0.01%
35,250
+10,853
+44% +$23.2K
11 12
13
14 15

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q1 2022 Portfolio in Review

As of Q1 2022, E Fund Management held 374 positions worth $3.06B, up 8% from $2.83B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

E Fund Management deployed $653M of net new capital in Q1 2022, opening 73 new positions and adding to 133 existing holdings. Its largest new stake was Natera: 6,882 shares worth $280K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 63% of assets, up from 61% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was United States Brent Oil Fund, an estimated $6.01M trimmed.

  • E Fund Management's largest Q1 2022 buy was Natera: 6,882 shares worth $280K.
  • E Fund Management added most to Alibaba in Q1 2022, an estimated $334M increase.
  • E Fund Management's biggest Q1 2022 reduction was United States Brent Oil Fund, cutting an estimated $6.01M.
  • E Fund Management fully exited NIO in Q1 2022, selling an estimated $10.7M.
  • E Fund Management's ten largest holdings make up 83% of its $3.06B portfolio in Q1 2022.
  • E Fund Management opened 73 new positions and closed 49 in Q1 2022.
  • E Fund Management's portfolio value rose 8% quarter-over-quarter to $3.06B.

Based on E Fund Management's 13F filing for Q1 2022, filed 12 May 2022.